R3R01 / River 3 Renal Corp - LARVOL DELTA

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis (clinicaltrials.gov) - P2 | N=50 | Active, not recruiting | Sponsor: River 3 Renal Corp. | Recruiting ➔ Active, not recruiting

Enrollment closed • Focal Segmental Glomerulosclerosis • Genetic Disorders • Glomerulonephritis • Renal Disease

Kidney ABC: The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease. (clinicaltrials.gov) - P2 | N=60 | Recruiting | Sponsor: River 3 Renal Corp. | Not yet recruiting ➔ Recruiting

Enrollment open • Diabetic Nephropathy • Nephrology • Renal Disease

Kidney ABC: The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients with Diabetic Kidney Disease. (clinicaltrials.gov) - P2 | N=60 | Not yet recruiting | Sponsor: River 3 Renal Corp.

New P2 trial • Diabetic Nephropathy • Nephrology • Renal Disease

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis (clinicaltrials.gov) - P2 | N=50 | Recruiting | Sponsor: River 3 Renal Corp. | Trial completion date: Sep 2024 ➔ Jun 2025 | Trial primary completion date: Sep 2024 ➔ Mar 2025

Trial completion date • Trial primary completion date • Focal Segmental Glomerulosclerosis • Genetic Disorders • Glomerulonephritis • Renal Disease

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis (clinicaltrials.gov) - P2 | N=50 | Recruiting | Sponsor: River 3 Renal Corp. | Trial completion date: Dec 2023 ➔ Sep 2024 | Trial primary completion date: Sep 2023 ➔ Sep 2024

Trial completion date • Trial primary completion date • Focal Segmental Glomerulosclerosis • Genetic Disorders • Glomerulonephritis • Renal Disease

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis (clinicaltrials.gov) - P2 | N=50 | Recruiting | Sponsor: River 3 Renal Corp. | Not yet recruiting ➔ Recruiting

Enrollment open • Focal Segmental Glomerulosclerosis • Genetic Disorders • Glomerulonephritis • Renal Disease